Tegra Medical11.14.16
Tegra Medical, a medical device contract manufacturer, today announced that SFS Group AG, a leading provider of customized precision formed components and mechanical fastening systems headquartered in Heerburg, Switzerland, is acquiring the company. Tegra Medical will become an SFS company and will continue usual operations under the Tegra Medical brand, with headquarters still located in Franklin, Mass. The senior management team, including president & CEO J. Mark King, CFO Craig Campbell, VP Sales and Marketing Lee Crowe, and VP GENESIS Tech Center Mike Treleaven will remain. J. Mark King will also take a position on the SFS Group Executive Board. Terms of the transaction have not been disclosed.
As the medical device marketplace evolves to support more outsourcing to contract manufacturers, this acquisition positions Tegra Medical to more easily grow along with our customers, while adding increased capabilities from SFS such as micro molding and cold forming. “As an end-to-end solutions provider, we are focused on meeting and exceeding our customers’ expectations,” said Tegra Medical president & CEO J. Mark King. “We’re all about being responsive and flexible; as an SFS company we’ll have even more resources to help us expand and offer what our customers need, where and when they need it.”
“This is an exciting time for the SFS Group because we’ve been looking for the right manufacturer to add focused medical device expertise to our company,” said Jens Breu, SFS Group CEO. “We are impressed with the breadth of Tegra Medical’s capabilities, the depth of their skills and experience, and the deep commitment of their employees. Not only is the company a great fit with our current manufacturing capabilities, we see synergy in terms of company principles, which include partnership, respect and a focus on the community.”
As the medical device marketplace evolves to support more outsourcing to contract manufacturers, this acquisition positions Tegra Medical to more easily grow along with our customers, while adding increased capabilities from SFS such as micro molding and cold forming. “As an end-to-end solutions provider, we are focused on meeting and exceeding our customers’ expectations,” said Tegra Medical president & CEO J. Mark King. “We’re all about being responsive and flexible; as an SFS company we’ll have even more resources to help us expand and offer what our customers need, where and when they need it.”
“This is an exciting time for the SFS Group because we’ve been looking for the right manufacturer to add focused medical device expertise to our company,” said Jens Breu, SFS Group CEO. “We are impressed with the breadth of Tegra Medical’s capabilities, the depth of their skills and experience, and the deep commitment of their employees. Not only is the company a great fit with our current manufacturing capabilities, we see synergy in terms of company principles, which include partnership, respect and a focus on the community.”